KeyBanc analyst Brett Fishbin has adjusted the company's price target on Integer Holdings (ITGR, Financial), reducing it from $154 to $145. Despite maintaining an Overweight rating for the shares, the decision reflects growing macroeconomic concerns. These include potential tariff impacts as well as heightened recession risks, which are causing adjustments in price targets across the board.
Nonetheless, the firm indicates that underlying trends within the MedTech sector show a largely positive trajectory as the market approaches the Q1 earnings season. The revision aims to align expectations with the current economic landscape while acknowledging the robustness of MedTech dynamics.
